Citations (162)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jieling Xiao, Cheng Han Ng, Kai En Chan, Ansel Shao Pin Tang, Readon Teh, Abel Ho Zhi Ling, Jie Ning Yong, Wen Hui Lim, Darren Jun Hao Tan, Caitlyn Tan, Khin Maung Win, Aung Hlaing Bwa, Nicholas W. S. Chew, Daniel Huang, Yock Young Dan, Mazen Noureddin, Mohammad Shadab Siddiqui, Arun Sanyal, Nobuharu Tamaki & Mark Muthiah. (2023) Complete alcohol abstinence increases the risk of NAFLD but not severity. A population analysis with transient elastography. Scandinavian Journal of Gastroenterology 58:1, pages 76-82.
Read now
Read now
Martin Kåberg, Simon B. Larsson, Anna Jerkeman, Anders Nystedt, Ann-Sofi Duberg, Jan Kövamees, Magdalena Ydreborg, Soo Aleman, Katharina Büsch, Marianne Alanko Blomé, Ola Weiland & Jonas Söderholm. (2020) High risk of non-alcoholic liver disease mortality in patients with chronic hepatitis C with illicit substance use disorder. Scandinavian Journal of Gastroenterology 55:5, pages 574-580.
Read now
Read now
Kristina Önnerhag, Peter M Nilsson & Stefan Lindgren. (2014) Increased risk of cirrhosis and hepatocellular cancer during long-term follow-up of patients with biopsy-proven NAFLD. Scandinavian Journal of Gastroenterology 49:9, pages 1111-1118.
Read now
Read now
Einar Björnsson. (2009) This month in the Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 44:3, pages 259-260.
Read now
Read now
Articles from other publishers (158)
Patrik Nasr, Axel Wester, Mattias Ekstedt, Rickard Strandberg, Stergios Kechagias, Ying Shang, Linnea Widman & Hannes Hagström. (2024) Misclassified Alcohol-related Liver Disease is Common in Presumed Metabolic Dysfunction-associated Steatotic Liver Disease and Highly Increases Risk for Future Cirrhosis. Clinical Gastroenterology and Hepatology 22:5, pages 1048-1057.e2.
Crossref
Crossref
Garth R. SwansonKanika Garg, Maliha ShaikhAli Keshavarzian. (2024) Increased Intestinal Permeability and Decreased Resiliency of the Intestinal Barrier in Alcoholic Liver Disease. Clinical and Translational Gastroenterology 15:4, pages e00689.
Crossref
Crossref
Diego Martínez-Urbistondo, Nuria Perez-Diaz-del-Campo, Manuel F. Landecho & J. Alfredo Martínez. (2024) Alcohol Drinking Impacts on Adiposity and Steatotic Liver Disease: Concurrent Effects on Metabolic Pathways and Cardiovascular Risks. Current Obesity Reports.
Crossref
Crossref
Hannes Hagström, Hannes Hegmar & Christophe Moreno. (2024) Interactions between the metabolic syndrome and alcohol consumption increases the risk of liver disease. United European Gastroenterology Journal 12:2, pages 168-176.
Crossref
Crossref
Silvia Andaloro, Fabrizio Mancuso, Luca Miele, Giovanni Addolorato, Antonio Gasbarrini & Francesca Romana Ponziani. (2024) Effect of Low-Dose Alcohol Consumption on Chronic Liver Disease. Nutrients 16:5, pages 613.
Crossref
Crossref
Simona Cernea. (2024) NAFLD Fibrosis Progression and Type 2 Diabetes: The Hepatic–Metabolic Interplay. Life 14:2, pages 272.
Crossref
Crossref
Katsutoshi Tokushige. (2024) New concept in fatty liver diseases. Hepatology Research 54:2, pages 125-130.
Crossref
Crossref
Manuel Romero-Gómez, Juan Pablo Arab, Claudia P. Oliveira, María Hernández, Marco Arrese, Helena Cortez-Pinto & Ramón Bataller. (2024) Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?. Seminars in Liver Disease 44:01, pages 069-078.
Crossref
Crossref
Robert J. Wong, Zeyuan Yang, Ramsey Cheung, Ashwani K. Singal, Albert Do, Aijaz Ahmed & Aaron Yeoh. (2024) Impact of Longitudinal Alcohol Use Patterns on Long-Term Risk of Cirrhosis Among US Veterans With Steatotic Liver Disease. Gastroenterology.
Crossref
Crossref
Udita Gupta, Thomas Ruli, Danyaal Buttar, Mohamed Shoreibah & Meagan Gray. (2024) Metabolic dysfunction associated steatotic liver disease: Current practice, screening guidelines and management in the primary care setting. The American Journal of the Medical Sciences 367:2, pages 77-88.
Crossref
Crossref
Kishan Dev Pithani & Radhika Vadhi. (2024) Enhanced non-alcoholic fatty liver detection: Computed tomography scan image analysis and noise reduction with morphological dilation. Arab Journal of Gastroenterology 25:1, pages 1-12.
Crossref
Crossref
Angelo Campanella, Caterina Bonfiglio, Francesco Cuccaro, Rossella Donghia, Rossella Tatoli & Gianluigi Giannelli. (2023) High Adherence to a Mediterranean Alcohol-Drinking Pattern and Mediterranean Diet Can Mitigate the Harmful Effect of Alcohol on Mortality Risk. Nutrients 16:1, pages 59.
Crossref
Crossref
Rodrigo Oliveira Moreira, Cynthia Melissa Valerio, Cristiane Alves Villela-Nogueira, Cintia Cercato, Fernando Gerchman, Ana Maria Pita Lottenberg, Amélio Fernando Godoy-Matos, Ricardo de Andrade Oliveira, Carlos Eduardo Brandão Mello, Mário Reis Álvares-da-Silva, Nathalie Carvalho Leite, Helma Pinchemel Cotrim, Edison Roberto Parisi, Giovanni Faria Silva, Paulo Augusto Carvalho Miranda, Bruno Halpern & Claudia Pinto Oliveira. (2023) Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso). Archives of Endocrinology and Metabolism 67:6.
Crossref
Crossref
Luis Antonio Díaz, Juan Pablo Arab, Alexandre Louvet, Ramón Bataller & Marco Arrese. (2023) The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 20:12, pages 764-783.
Crossref
Crossref
Helmut K. Seitz & Ulrich John. (2023) Gesundheitsrisiko Alkohol – neue Empfehlungen zum Umgang mit AlkoholAlcohol as a health risk: new recommendations for dealing with alcohol. Die Innere Medizin 64:12, pages 1224-1229.
Crossref
Crossref
Patrik Nasr, Cecilia Jönsson, Mattias Ekstedt & Stergios Kechagias. (2023) Non-metabolic causes of steatotic liver disease. Metabolism and Target Organ Damage 3:4.
Crossref
Crossref
Gi-Ae Kim, Joon Ho Moon & Won Kim. (2023) Critical appraisal of metabolic dysfunction-associated steatotic liver disease: Implication of Janus-faced modernity. Clinical and Molecular Hepatology 29:4, pages 831-843.
Crossref
Crossref
Jessica Rosenberg, Orlando Sola & Adam Visconti. (2023) Approach to Elevated Liver Enzymes. Primary Care: Clinics in Office Practice 50:3, pages 363-376.
Crossref
Crossref
Raluca Pais, Bertrand Cariou, Mazen Noureddin, Sven Francque, Jörn M. Schattenberg, Manal F. Abdelmalek, Gadi Lalazar, Sharat Varma, Julie Dietrich, Veronica Miller, Arun Sanyal & Vlad Ratziu. (2023) A proposal from the liver forum for the management of comorbidities in non-alcoholic steatohepatitis therapeutic trials. Journal of Hepatology 79:3, pages 829-841.
Crossref
Crossref
Mary E. Rinella, Brent A. Neuschwander-Tetri, Mohammad Shadab Siddiqui, Manal F. Abdelmalek, Stephen Caldwell, Diana Barb, David E. Kleiner & Rohit Loomba. (2023) AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology 77:5, pages 1797-1835.
Crossref
Crossref
Aitor Odriozola, Alvaro Santos-Laso, María del Barrio, Joaquín Cabezas, Paula Iruzubieta, María Teresa Arias-Loste, Coral Rivas, Juan Carlos Rodríguez Duque, Ángela Antón, Emilio Fábrega & Javier Crespo. (2023) Fatty Liver Disease, Metabolism and Alcohol Interplay: A Comprehensive Review. International Journal of Molecular Sciences 24:9, pages 7791.
Crossref
Crossref
Ji-Won Park & Ki Tae Suk. (2023) The effect of moderate alcohol consumption on nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 29:2, pages 408-410.
Crossref
Crossref
Louise Magherman, Robbe Van Parys, Nele S. Pauwels, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts & Sander Lefere. (2023) Meta‐analysis: The impact of light‐to‐moderate alcohol consumption on progressive non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 57:8, pages 820-836.
Crossref
Crossref
Lorenzo Leggio & Jessica L. Mellinger. (2023) Alcohol use disorder in community management of chronic liver diseases. Hepatology 77:3, pages 1006-1021.
Crossref
Crossref
Chimaobi Anugwom, Mary Thomson, Rebecca L Freese, John R Lake & Nicholas Lim. (2023) Lower survival and higher rates of cirrhosis in patients with ROUX-EN-Y gastric bypass hospitalised with alcohol-associated hepatitis. BMJ Open Gastroenterology 10:1, pages e001083.
Crossref
Crossref
Georgios Sfikas & Ioannis Valsamidis. 2023. Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis. Non-alcoholic Fatty Liver Disease - New Insight and Glance Into Disease Pathogenesis.
Julia Blomdahl, Patrik Nasr, Mattias Ekstedt & Stergios Kechagias. (2023) Moderate alcohol consumption is associated with significant fibrosis progression in NAFLD. Hepatology Communications 7:1, pages e0003-e0003.
Crossref
Crossref
Fredrik Åberg, Christopher D. Byrne, Carlos J. Pirola, Ville Männistö & Silvia Sookoian. (2023) Alcohol consumption and metabolic syndrome: Clinical and epidemiological impact on liver disease. Journal of Hepatology 78:1, pages 191-206.
Crossref
Crossref
Sara K. Naramore, Kyla Tolliver & Kathryn Harlow Adams. 2023. Managing Pediatric Obesity Using Advanced Therapies. Managing Pediatric Obesity Using Advanced Therapies
305
324
.
Liana Gheorghe & Speranta Iacob. 2023. Essentials of Non-Alcoholic Fatty Liver Disease. Essentials of Non-Alcoholic Fatty Liver Disease
133
147
.
Hannes Hegmar & Hannes Hagström. 2023. Alcohol and Alcohol-related Diseases. Alcohol and Alcohol-related Diseases
953
973
.
Gustavo Marino, Ibrahim M. Zeini & Muhammad Ghanem. 2023. Duodenal Switch and Its Derivatives in Bariatric and Metabolic Surgery. Duodenal Switch and Its Derivatives in Bariatric and Metabolic Surgery
95
103
.
Moon Nyeo Park, Md. Ataur Rahman, Md. Hasanur Rahman, Jong Woo Kim, Min Choi, Jeong Woo Kim, Jinwon Choi, Myunghan Moon, Kazi Rejvee Ahmed & Bonglee Kim. (2022) Potential Therapeutic Implication of Herbal Medicine in Mitochondria-Mediated Oxidative Stress-Related Liver Diseases. Antioxidants 11:10, pages 2041.
Crossref
Crossref
Roman Dascal, Colin Rumbolt, Julia Uhanova, Daria Surina, Grace Oketola, Byron Beardy & Gerald Y Minuk. (2022) Binge drinking does not appear to have an adverse effect on non-alcoholic fatty liver disease: Findings from a study of four First Nations communities. Canadian Liver Journal.
Crossref
Crossref
Maria Irene Bellini, Irene Urciuoli, Giovanni Del Gaudio, Giorgia Polti, Giovanni Iannetti, Elena Gangitano, Eleonora Lori, Carla Lubrano, Vito Cantisani, Salvatore Sorrenti & Vito D’Andrea. (2022) Nonalcoholic fatty liver disease and diabetes. World Journal of Diabetes 13:9, pages 668-682.
Crossref
Crossref
Lei Fan, Xiangzhu Zhu, Alexandra Shingina, Edmond K. Kabagambe, Martha J. Shrubsole & Qi Dai. (2022) Racial Disparities in Associations of Alcohol Consumption With Liver Disease Mortality in a Predominantly Low-Income Population: A Report From the Southern Community Cohort Study. American Journal of Gastroenterology 117:9, pages 1523-1529.
Crossref
Crossref
. (2022) Updated S2k Clinical Practice Guideline on Non-alcoholic Fatty Liver Disease (NAFLD) issued by the German Society of Gastroenterology, Digestive and Metabolic Diseases (DGVS) – April 2022 – AWMF Registration No.: 021–025. Zeitschrift für Gastroenterologie 60:09, pages e733-e801.
Crossref
Crossref
E. Roeb, A. Canbay, H. Bantel, J. Bojunga, J. de Laffolie, M. Demir, U. W. Denzer, A. Geier, W. P. Hofmann, C. Hudert, T. Karlas, M. Krawczyk, T. Longerich, T. Luedde, M. Roden, J. Schattenberg, M. Sterneck, A. Tannapfel, P. Lorenz & F. Tacke. (2022) Aktualisierte S2k-Leitlinie nicht-alkoholische Fettlebererkrankung der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – April 2022 – AWMF-Registernummer: 021–025. Zeitschrift für Gastroenterologie 60:09, pages 1346-1421.
Crossref
Crossref
Joud Alalwani, Sereen Eljazzar, Maya Basil & Reema Tayyem. (2022)
The impact of health status, diet and lifestyle on
non‐alcoholic
fatty liver disease: Narrative review
. Clinical Obesity 12:4.
Crossref
Crossref
Pierpaolo Pellicori, Muthiah Vaduganathan, João Pedro Ferreira, Faiez Zannad & Arun J. Sanyal. (2022) Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design. Diabetes & Metabolism 48:2, pages 101281.
Crossref
Crossref
Yedidya Saiman, Andres Duarte-Rojo & Mary E. Rinella. (2022) Fatty Liver Disease: Diagnosis and Stratification. Annual Review of Medicine 73:1, pages 529-544.
Crossref
Crossref
Helen Jarvis, Hannah O'Keefe, Dawn Craig, Daniel Stow, Barbara Hanratty & Quentin M Anstee. (2022) Does moderate alcohol consumption accelerate the progression of liver disease in NAFLD? A systematic review and narrative synthesis. BMJ Open 12:1, pages e049767.
Crossref
Crossref
Shuhei Onishi, Nobuyuki Miyai, Yan Zhang, Toshifumi Oka, Eriko Nogami, Miyoko Utsumi & Mikio Arita. (2021) Excessive alcohol intake and liver fibrosis are associated with skeletal muscle mass reduction in elderly men: the Wakayama study. Aging Clinical and Experimental Research 34:1, pages 185-192.
Crossref
Crossref
Felix Stickel & Christian Datz. 2022. Nicht-alkoholische Fettlebererkrankung. Nicht-alkoholische Fettlebererkrankung
367
373
.
Wayne Eskridge, John M. Vierling, Wayne Gosbee, Gabriella A. Wan, May-Linh Hyunh & Henry E. Chang. (2021) Screening for undiagnosed non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): A population-based risk factor assessment using vibration controlled transient elastography (VCTE). PLOS ONE 16:11, pages e0260320.
Crossref
Crossref
Sven M. Francque, Giulio Marchesini, Achim Kautz, Martine Walmsley, Rebecca Dorner, Jeffrey V. Lazarus, Shira Zelber-Sagi, Kate Hallsworth, Luca Busetto, Gema Frühbeck, Dror Dicker, Euan Woodward, Marko Korenjak, José Willemse, Gerardus H. Koek, Shlomo Vinker, Mehmet Ungan, Juan M. Mendive & Christos Lionis. (2021) Non-alcoholic fatty liver disease: A patient guideline. JHEP Reports 3:5, pages 100322.
Crossref
Crossref
Wasit Wongtrakul, Sorachat Niltwat & Phunchai Charatcharoenwitthaya. (2021) The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Frontiers in Medicine 8.
Crossref
Crossref
Shira Zelber-Sagi. (2021) Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations. Seminars in Liver Disease 41:03, pages 248-262.
Crossref
Crossref
Dina Mansour, Allison Grapes, Marc Herscovitz, Paul Cassidy, Jonathan Vernazza, Andrea Broad, Quentin M. Anstee & Stuart McPherson. (2021) Embedding assessment of liver fibrosis into routine diabetic review in primary care. JHEP Reports 3:4, pages 100293.
Crossref
Crossref
Agostino Di Ciaula, Giuseppe Calamita, Harshitha Shanmugam, Mohamad Khalil, Leonilde Bonfrate, David Q.-H. Wang, Gyorgy Baffy & Piero Portincasa. (2021) Mitochondria Matter: Systemic Aspects of Nonalcoholic Fatty Liver Disease (NAFLD) and Diagnostic Assessment of Liver Function by Stable Isotope Dynamic Breath Tests. International Journal of Molecular Sciences 22:14, pages 7702.
Crossref
Crossref
Fu-Rong Sun & Bing-Yuan Wang. (2021) Alcohol and Metabolic-associated Fatty Liver Disease. Journal of Clinical and Translational Hepatology 000:000, pages 000-000.
Crossref
Crossref
Seong Hee Kang, Hye Won Lee, Jeong-Ju Yoo, Yuri Cho, Seung Up Kim, Tae Hee Lee, Byoung Kuk Jang, Sang Gyune Kim, Sang Bong Ahn, Haeryoung Kim, Dae Won Jun, Joon-Il Choi, Do Seon Song, Won Kim, Soung Won Jeong, Moon Young Kim, Hong Koh, Sujin Jeong, Jin-Woo Lee & Yong Kyun Cho. (2021) KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 27:3, pages 363-401.
Crossref
Crossref
Freya Alison Rhodes, Sara Cococcia, Preya Patel, Jasmina Panovska-Griffiths, Sudeep Tanwar, Rachel H Westbrook, Alison Rodger & William Rosenberg. (2021) Is there scope to improve the selection of patients with alcohol-related liver disease for referral to secondary care? A retrospective analysis of primary care referrals to a UK liver centre, incorporating simple blood tests. BMJ Open 11:6, pages e047786.
Crossref
Crossref
Ana Carolina Cardoso, Claudio de Figueiredo‐Mendes & Cristiane A. Villela‐Nogueira. (2021) Current management of NAFLD/NASH. Liver International 41:S1, pages 89-94.
Crossref
Crossref
Agostino Di Ciaula, Salvatore Passarella, Harshitha Shanmugam, Marica Noviello, Leonilde Bonfrate, David Q.-H. Wang & Piero Portincasa. (2021) Nonalcoholic Fatty Liver Disease (NAFLD). Mitochondria as Players and Targets of Therapies?. International Journal of Molecular Sciences 22:10, pages 5375.
Crossref
Crossref
Colin Rumbolt & Gerald Y Minuk. (2021) The effects of binge drinking on healthy and diseased livers. Canadian Liver Journal 4:2, pages 93-98.
Crossref
Crossref
Pankaj Puri, Radha K. Dhiman, Sunil Taneja, Puneeta Tandon, Manuela Merli, Anil C. Anand, Anil Arora, Subrat K. Acharya, Jaya Benjamin, Yogesh K. Chawla, Sunil Dadhich, Ajay Duseja, C.E. Eapan, Amit Goel, Naveen Kalra, Dharmesh Kapoor, Ashish Kumar, Kaushal Madan, Aabha Nagral, Gaurav Pandey, Padaki N. Rao, Sanjiv Saigal, Neeraj Saraf, Vivek A. Saraswat, Anoop Saraya, Shiv K. Sarin, Praveen Sharma, Shalimar, Akash Shukla, Sandeep S. Sidhu, Namrata Singh, Shivaram P. Singh, Anshu Srivastava & Manav Wadhawan. (2021) Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. Journal of Clinical and Experimental Hepatology 11:1, pages 97-143.
Crossref
Crossref
Alper Sonmez, Cemal Nuri Ercin, Mustafa Cesur & Teoman Dogru. 2021. Nutraceuticals and Cardiovascular Disease. Nutraceuticals and Cardiovascular Disease
141
165
.
Ignazio Grattagliano, Agostino Di Ciaula, Jacek Baj, Emilio Molina-Molina, Harshitha Shanmugam, Gabriella Garruti, David Q. -H. Wang & Piero Portincasa. 2021. Mitochondrial Regulation. Mitochondrial Regulation
201
246
.
K. L. Raikhelson, E. A. Kondrashina & E. V. Pazenko. (2020) Mixed steatohepatitis: more questions than answers (Part 1). Terapevticheskii arkhiv 92:12, pages 91-96.
Crossref
Crossref
Sakura Yamamura, Mohammed Eslam, Takumi Kawaguchi, Tsubasa Tsutsumi, Dan Nakano, Shinobu Yoshinaga, Hirokazu Takahashi, Keizo Anzai, Jacob George & Takuji Torimura. (2020) MAFLD identifies patients with significant hepatic fibrosis better than NAFLD. Liver International 40:12, pages 3018-3030.
Crossref
Crossref
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata & Jacob George. (2020) The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease. Hepatology International 14:6, pages 889-919.
Crossref
Crossref
Jong Hwa Choi, Won Sohn & Yong Kyun Cho. (2020) The effect of moderate alcohol drinking in nonalcoholic fatty liver disease. Clinical and Molecular Hepatology 26:4, pages 662-669.
Crossref
Crossref
Theresa J. Hydes, Sujan Ravi, Rohit Loomba & Meagan E. Gray. (2020) Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH. Clinical and Molecular Hepatology 26:4, pages 383-400.
Crossref
Crossref
Stergios Kechagias, Patrik Nasr, Julia Blomdahl & Mattias Ekstedt. (2020) Established and emerging factors affecting the progression of nonalcoholic fatty liver disease. Metabolism 111, pages 154183.
Crossref
Crossref
Phei Oon Tan, Nazri Mustaffa, Soek Siam Tan & Yeong Yeh Lee. (2020) Diagnosis and Management of Fatty Liver. Journal of the Royal College of Physicians of Edinburgh 50:3, pages 256-261.
Crossref
Crossref
Francisco Idalsoaga, Anand V. Kulkarni, Omar Y. Mousa, Marco Arrese & Juan Pablo Arab. (2020) Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities. Frontiers in Medicine 7.
Crossref
Crossref
Sara Ghoneim, Muhammad Umer Butt, Sophie Trujillo & Imad Asaad. (2020) FIB-4 Regression With Direct-Acting Antiviral Therapy in Patients With Hepatitis C Infection: A Safety-Net Hospital Experience. Frontiers in Medicine 7.
Crossref
Crossref
Michelle T. Long, Joseph M. Massaro, Udo Hoffmann, Emelia J. Benjamin & Timothy S. Naimi. (2020) Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology 18:8, pages 1831-1841.e5.
Crossref
Crossref
Yasser Fouad, Imam Waked, Steven Bollipo, Ahmed Gomaa, Yousef Ajlouni & Dina Attia. (2020) What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’. Liver International 40:6, pages 1254-1261.
Crossref
Crossref
Line Carolle Ntandja Wandji, Viviane Gnemmi, Philippe Mathurin & Alexandre Louvet. (2020) Combined alcoholic and non-alcoholic steatohepatitis. JHEP Reports 2:3, pages 100101.
Crossref
Crossref
Mohammed Eslam, Arun J. Sanyal, Jacob George, Arun Sanyal, Brent Neuschwander-Tetri, Claudio Tiribelli, David E. Kleiner, Elizabeth Brunt, Elisabetta Bugianesi, Hannele Yki-Järvinen, Henning Grønbæk, Helena Cortez-Pinto, Jacob George, Jiangao Fan, Luca Valenti, Manal Abdelmalek, Manuel Romero-Gomez, Mary Rinella, Marco Arrese, Mohammed Eslam, Pierre Bedossa, Philip N. Newsome, Quentin M. Anstee, Rajiv Jalan, Ramon Bataller, Rohit Loomba, Silvia Sookoian, Shiv K. Sarin, Stephen Harrison, Takumi Kawaguchi, Vincent Wai-Sun Wong, Vlad Ratziu, Yusuf Yilmaz & Zobair Younossi. (2020) MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease. Gastroenterology 158:7, pages 1999-2014.e1.
Crossref
Crossref
Adeyinka C. Adejumo, George Cholankeril, Umair Iqbal, Eric R. Yoo, Brian C. Boursiquot, Waldo C. Concepcion, Donghee Kim & Aijaz Ahmed. (2019) Readmission Rates and Associated Outcomes for Alcoholic Hepatitis: A Nationwide Cohort Study. Digestive Diseases and Sciences 65:4, pages 990-1002.
Crossref
Crossref
Samuel J. Daniels, Diana J. Leeming, Sönke Detlefsen, Maria F. Bruun, Sara T. Hjuler, Kim Henriksen, Peter Hein, Aleksander Krag, Morten A. Karsdal, Mette Juul Nielsen, Sarah Brockbank & Simon Cruwys. (2020) Addition of trans fat and alcohol has divergent effects on atherogenic diet-induced liver injury in rodent models of steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 318:3, pages G410-G418.
Crossref
Crossref
Yoosoo Chang, Seungho Ryu, Yejin Kim, Yong Kyun Cho, Eunju Sung, Han‐Na Kim, Jiin Ahn, Hyun‐Suk Jung, Kyung Eun Yun, Seolhye Kim, Ki‐Chul Sung, Chong Il Sohn, Hocheol Shin, Sarah H. Wild & Christopher D. Byrne. (2019) Low Levels of Alcohol Consumption, Obesity, and Development of Fatty Liver With and Without Evidence of Advanced Fibrosis. Hepatology 71:3, pages 861-873.
Crossref
Crossref
Fredrik Åberg, Martti Färkkilä & Ville Männistö. (2020) Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies. Alcoholism: Clinical and Experimental Research 44:2, pages 384-403.
Crossref
Crossref
Helmut K. Seitz. (2020) The role of cytochrome P4502E1 in the pathogenesis of alcoholic liver disease and carcinogenesis. Chemico-Biological Interactions 316, pages 108918.
Crossref
Crossref
Dina G. Tiniakos & Stratigoula Sakellariou. 2020. Non-Alcoholic Fatty Liver Disease. Non-Alcoholic Fatty Liver Disease
25
47
.
Maya Margalit, Hanny Yeshua, Neta Gotlieb & Shira Zelber-Sagi. 2020. NAFLD and NASH. NAFLD and NASH
11
27
.
Maria L. Petroni, Lucia Brodosi, Francesca Marchignoli, Alessandra Musio & Giulio Marchesini. (2019) Moderate Alcohol Intake in Non-Alcoholic Fatty Liver Disease: To Drink or Not to Drink?. Nutrients 11:12, pages 3048.
Crossref
Crossref
George Khoudari, Amandeep Singh, Mazen Noureddin, Danielle Fritze, Rocio Lopez, Imad Asaad, Eric Lawitz, Fred Poordad, Kris V Kowdley & Naim Alkhouri. (2019) Characterization of patients with both alcoholic and nonalcoholic fatty liver disease in a large United States cohort. World Journal of Hepatology 11:10, pages 710-718.
Crossref
Crossref
Mohammed Eslam, Arun J. Sanyal & Jacob George. (2019) Toward More Accurate Nomenclature for Fatty Liver Diseases. Gastroenterology 157:3, pages 590-593.
Crossref
Crossref
Kaveh Hajifathalian, Babak Torabi Sagvand & Arthur J. McCullough. (2018) Effect of Alcohol Consumption on Survival in Nonalcoholic Fatty Liver Disease: A National Prospective Cohort Study. Hepatology 70:2, pages 511-521.
Crossref
Crossref
Nooshin Hosseini, Julia Shor & Gyongyi Szabo. (2019) Alcoholic Hepatitis: A Review. Alcohol and Alcoholism 54:4, pages 408-416.
Crossref
Crossref
Anna Jeznach-Steinhagen, Joanna Ostrowska, Aneta Czerwonogrodzka-Senczyna, Iwona Boniecka, Urszula Shahnazaryan & Alina Kuryłowicz. (2019) Dietary and Pharmacological Treatment of Nonalcoholic Fatty Liver Disease. Medicina 55:5, pages 166.
Crossref
Crossref
Inbeom Kwon, Dae Won Jun & Jin-Hwa Moon. (2019) Effects of Moderate Alcohol Drinking in Patients with Nonalcoholic Fatty Liver Disease. Gut and Liver 13:3, pages 308-314.
Crossref
Crossref
Esther van Eekelen, Joline W J Beulens, Anouk Geelen, Vera B Schrauwen-Hinderling, Hildo Lamb, Albert de Roos, Frits Rosendaal & Renée de Mutsert. (2019) Consumption of Alcoholic and Sugar-Sweetened Beverages is Associated with Increased Liver Fat Content in Middle-Aged Men and Women. The Journal of Nutrition 149:4, pages 649-658.
Crossref
Crossref
Iraklis Perysinakis, Harilaos C. Pappis & Elias Margaris. (2019) Current Controversies in Metabolic Surgery for Nonalcoholic Fatty Liver Disease. Obesity Surgery 29:3, pages 1058-1067.
Crossref
Crossref
Gurmehr Brar & Hidekazu Tsukamoto. (2019) Alcoholic and non-alcoholic steatohepatitis: global perspective and emerging science. Journal of Gastroenterology 54:3, pages 218-225.
Crossref
Crossref
Ignazio Grattagliano, Liliana P. Montezinho, Paulo J. Oliveira, Gema Frühbeck, Javier Gómez-Ambrosi, Fabrizio Montecucco, Federico Carbone, Mariusz R. Wieckowski, David Q.-H. Wang & Piero Portincasa. (2019) Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease. Biochemical Pharmacology 160, pages 34-45.
Crossref
Crossref
Stefanos Tyrovolas, Demosthenes B. Panagiotakos, Ekavi N. Georgousopoulou, Christina Chrysohoou, John Skoumas, William Pan, Dimitrios Tousoulis & Christos Pitsavos. (2019) The anti-inflammatory potential of diet and nonalcoholic fatty liver disease: the ATTICA study. Therapeutic Advances in Gastroenterology 12, pages 175628481985803.
Crossref
Crossref
Yoosoo Chang, Yong Kyun Cho, Yejin Kim, Eunju Sung, Jiin Ahn, Hyun‐Suk Jung, Kyung Eun Yun, Hocheol Shin & Seungho Ryu. (2018) Nonheavy Drinking and Worsening of Noninvasive Fibrosis Markers in Nonalcoholic Fatty Liver Disease: A Cohort Study. Hepatology 69:1, pages 64-75.
Crossref
Crossref
Helmut K. Seitz, Ramon Bataller, Helena Cortez-Pinto, Bin Gao, Antoni Gual, Carolin Lackner, Philippe Mathurin, Sebastian Mueller, Gyongyi Szabo & Hidekazu Tsukamoto. (2018) Alcoholic liver disease. Nature Reviews Disease Primers 4:1.
Crossref
Crossref
Furong Sun, Zhenjie Zhuang, Dai Zhang, Yushuai Chen, Shu Liu, Nan Gao, Junping Shi & Bingyuan Wang. (2018) Chronic moderate alcohol consumption relieves high‐fat high‐cholesterol diet‐induced liver fibrosis in a rat model. Clinical and Experimental Pharmacology and Physiology 45:10, pages 1046-1055.
Crossref
Crossref
Matthew J. Armstrong, Jessica L. Mellinger & Palak J. Trivedi. (2018) Alcohol Consumption in Patients with Non-alcoholic Fatty Liver Disease: Convenient vs. Inconvenient Truths. American Journal of Gastroenterology 113:10, pages 1437-1439.
Crossref
Crossref
Tim Mitchell, Gary P. Jeffrey, Bastiaan de Boer, Gerry MacQuillan, George Garas, Helena Ching, Jeffrey Hamdorf & Leon A. Adams. (2018) Type and Pattern of Alcohol Consumption is Associated With Liver Fibrosis in Patients With Non-alcoholic Fatty Liver Disease. American Journal of Gastroenterology 113:10, pages 1484-1493.
Crossref
Crossref
Luigi Schiavo, Luca Busetto, Manuela Cesaretti, Shira Zelber-Sagi, Liat Deutsch & Antonio Iannelli. (2018) Nutritional issues in patients with obesity and cirrhosis. World Journal of Gastroenterology 24:30, pages 3330-3346.
Crossref
Crossref
Kenichi Ikejima. (2018) Cutting-edge topics in the pathophysiology of alcoholic liver diseaseアルコール性肝障害機序の最先端. Kanzo 59:7, pages 342-350.
Crossref
Crossref
Richard Parker. (2018) The role of adipose tissue in fatty liver diseases. Liver Research 2:1, pages 35-42.
Crossref
Crossref
Christian Bayerl, Roberto Lorbeer, Margit Heier, Christa Meisinger, Susanne Rospleszcz, Anina Schafnitzel, Hannah Patscheider, Sigrid Auweter, Annette Peters, Birgit Ertl-Wagner, Maximilian Reiser, Fabian Bamberg & Holger Hetterich. (2018) Alcohol consumption, but not smoking is associated with higher MR-derived liver fat in an asymptomatic study population. PLOS ONE 13:2, pages e0192448.
Crossref
Crossref
D. J. Harman, S. D. Ryder, M. W. James, E. A. Wilkes, T. R. Card, G. P. Aithal & I. N. Guha. (2017) Obesity and type 2 diabetes are important risk factors underlying previously undiagnosed cirrhosis in general practice: a cross‐sectional study using transient elastography. Alimentary Pharmacology & Therapeutics 47:4, pages 504-515.
Crossref
Crossref
Marie Boyle, Steven Masson & Quentin M. Anstee. (2018) The bidirectional impacts of alcohol consumption and the metabolic syndrome: Cofactors for progressive fatty liver disease. Journal of Hepatology 68:2, pages 251-267.
Crossref
Crossref
Maham Lodhi, Jaimin Amin & Sheila Eswaran. (2018) Role of alcohol in nonalcoholic steatohepatitis: Rush university (Con) patients with nonalcoholic steatohepatitis should be abstinent from alcohol use. Clinical Liver Disease 11:2, pages 39-42.
Crossref
Crossref
Elena S George, Adrienne Forsyth, Catherine Itsiopoulos, Amanda J Nicoll, Marno Ryan, Siddharth Sood, Stuart K Roberts & Audrey C Tierney. (2018) Practical Dietary Recommendations for the Prevention and Management of Nonalcoholic Fatty Liver Disease in Adults. Advances in Nutrition 9:1, pages 30-40.
Crossref
Crossref
Richard Parker, Seung-Jin Kim & Bin Gao. (2017) Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nature Reviews Gastroenterology & Hepatology 15:1, pages 50-59.
Crossref
Crossref
Dina G. Tiniakos, Quentin M. Anstee & Alastair D. Burt. 2018. Macsween's Pathology of the Liver. Macsween's Pathology of the Liver
308
371
.
Stefan G. Hübscher. 2018. Practical Hepatic Pathology: a Diagnostic Approach. Practical Hepatic Pathology: a Diagnostic Approach
371
390
.
Lucija Virović-Jukić, Jelena Forgač, Doris Ogresta, Tajana Filipec-Kanižaj & Anna Mrzljak. 2018. Gastrointestinal Complications of Diabetes. Gastrointestinal Complications of Diabetes
275
315
.
Ekaterina E. Mishina, Alexander Y. Mayorov, Pavel O. Bogomolov, Maria V. Matsievich, Ksenia Y. Kokina & Apollinariya V. Bogolyubova. (2017) Nonalcoholic fatty liver disease: cause or consequence of insulin resistance?. Diabetes mellitus 20:5, pages 335-343.
Crossref
Crossref
Lisa B. VanWagner, Hongyan Ning, Norrina B. Allen, Veeral Ajmera, Cora E. Lewis, John Jeffrey Carr, Donald M. Lloyd-Jones, Norah A. Terrault & Juned Siddique. (2017) Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology 153:5, pages 1260-1272.e3.
Crossref
Crossref
Mack C. Mitchell & Gyongyi Szabo. 2017. Schiff's Diseases of the Liver. Schiff's Diseases of the Liver
699
739
.
Hannes Hagström. (2017) Alcohol, smoking and the liver disease patient. Best Practice & Research Clinical Gastroenterology 31:5, pages 537-543.
Crossref
Crossref
George Cholankeril, Robert J. Wong, Menghan Hu, Ryan B. Perumpail, Eric R. Yoo, Puneet Puri, Zobair M. Younossi, Stephen A. Harrison & Aijaz Ahmed. (2017) Liver Transplantation for Nonalcoholic Steatohepatitis in the US: Temporal Trends and Outcomes. Digestive Diseases and Sciences 62:10, pages 2915-2922.
Crossref
Crossref
Fredrik Åberg, Jaana Helenius‐Hietala, Pauli Puukka & Antti Jula. (2017) Binge drinking and the risk of liver events: A population‐based cohort study. Liver International 37:9, pages 1373-1381.
Crossref
Crossref
Shira Zelber‐Sagi, Federico Salomone & Liat Mlynarsky. (2017) The Mediterranean dietary pattern as the diet of choice for non‐alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver International 37:7, pages 936-949.
Crossref
Crossref
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán & Juan Pedro-Botet. (2017) Enfermedad del hígado graso no alcohólico, asociación con la enfermedad cardiovascular y tratamiento (II). Tratamiento de la enfermedad del hígado graso no alcohólico. Clínica e Investigación en Arteriosclerosis 29:4, pages 185-200.
Crossref
Crossref
Ángel Brea, Xavier Pintó, Juan F. Ascaso, Mariano Blasco, Ángel Díaz, Pedro González-Santos, Antonio Hernández-Mijares, Teresa Mantilla, Jesús Millán & Juan Pedro-Botet. (2017) Nonalcoholic fatty liver disease, association with cardiovascular disease and treatment (II). The treatment of nonalcoholic fatty liver disease. Clínica e Investigación en Arteriosclerosis (English Edition) 29:4, pages 185-200.
Crossref
Crossref
Bubu A Banini & Arun J Sanyal. (2017) Treatment of NASH: What Helps Beyond Weight Loss?. American Journal of Gastroenterology 112:6, pages 821-824.
Crossref
Crossref
Hannes Hagström. (2017) Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?. Current Hepatology Reports 16:2, pages 152-157.
Crossref
Crossref
Iliana Doycheva, Kymberly D. Watt & Naim Alkhouri. (2017) Nonalcoholic fatty liver disease in adolescents and young adults: The next frontier in the epidemic. Hepatology 65:6, pages 2100-2109.
Crossref
Crossref
Veeral H. Ajmera, Norah A. Terrault & Stephen A. Harrison. (2017) Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology 65:6, pages 2090-2099.
Crossref
Crossref
Elizabeth C Verna. (2017) Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV. The Lancet Gastroenterology & Hepatology 2:3, pages 211-223.
Crossref
Crossref
Miriam B. Vos, Stephanie H. Abrams, Sarah E. Barlow, Sonia Caprio, Stephen R. Daniels, Rohit Kohli, Marialena Mouzaki, Pushpa Sathya, Jeffrey B. Schwimmer, Shikha S. Sundaram & Stavra A. Xanthakos. (2017) NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children. Journal of Pediatric Gastroenterology and Nutrition 64:2, pages 319-334.
Crossref
Crossref
Preya J. Patel, David Smith, Jason P. Connor, Leigh U. Horsfall, Kelly L. Hayward, Fabrina Hossain, Suzanne Williams, Tracey Johnson, Katherine A. Stuart, Nigel N. Brown, Nivene Saad, Andrew D. Clouston, Katharine M. Irvine, Anthony W. Russell, Patricia C. Valery & Elizabeth E. Powell. (2017) Alcohol Consumption in Diabetic Patients with Nonalcoholic Fatty Liver Disease. Canadian Journal of Gastroenterology and Hepatology 2017, pages 1-8.
Crossref
Crossref
Stefano Bellentani. (2017) The epidemiology of non‐alcoholic fatty liver disease. Liver International 37:S1, pages 81-84.
Crossref
Crossref
Teruki Miyake, Teru Kumagi, Masashi Hirooka, Shinya Furukawa, Osamu Yoshida, Mitsuhito Koizumi, Shin Yamamoto, Takao Watanabe, Yasunori Yamamoto, Yoshio Tokumoto, Eiji Takeshita, Masanori Abe, Kohichiro Kitai, Bunzo Matsuura & Yoichi Hiasa. (2016) Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease. Journal of Gastroenterology 51:11, pages 1090-1100.
Crossref
Crossref
Suzanne E. Mahady & Jacob George. (2016) Exercise and diet in the management of nonalcoholic fatty liver disease. Metabolism 65:8, pages 1172-1182.
Crossref
Crossref
Christine C. Hsu & Kris V. Kowdley. (2016) The Effects of Alcohol on Other Chronic Liver Diseases. Clinics in Liver Disease 20:3, pages 581-594.
Crossref
Crossref
Katsutoshi Tokushige, Hideyuki Hyogo, Tomoaki Nakajima, Masafumi Ono, Takumi Kawaguchi, Koichi Honda, Yuichiro Eguchi, Yuichi Nozaki, Miwa Kawanaka, Saiyu Tanaka, Kento Imajo, Yoshio Sumida, Yoshihiro Kamada, Hideki Fujii, Yasuaki Suzuki, Tomomi Kogiso, Yoshiyasu Karino, Kensuke Munekage, Ryoko Kuromatsu, Satoshi Oeda, Mikio Yanase, Kohjiro Mori, Yuji Ogawa, Yuya Seko, Tetsuo Takehara, Yoshito Itoh, Atsushi Nakajima, Kazuyuki Kanemasa, Ken Nishino, Naohiko Masaki, Hirokazu Takahashi, Masataka Seike, Takuji Torimura, Toshiji Saibara, Joji Toyota, Kazuaki Chayama & Etsuko Hashimoto. (2015) Hepatocellular carcinoma in Japanese patients with nonalcoholic fatty liver disease and alcoholic liver disease: multicenter survey. Journal of Gastroenterology 51:6, pages 586-596.
Crossref
Crossref
Mariana Lazo & Mack C. Mitchell. 2016. Alcoholic and Non-Alcoholic Fatty Liver Disease. Alcoholic and Non-Alcoholic Fatty Liver Disease
1
20
.
C. W. Kim & H. Y. Kim. (2015) Letter: association between moderate alcohol consumption and non‐alcoholic fatty liver disease. Alimentary Pharmacology & Therapeutics 42:11-12, pages 1330-1331.
Crossref
Crossref
Aijaz Ahmed, Robert J. Wong & Stephen A. Harrison. (2015) Nonalcoholic Fatty Liver Disease Review: Diagnosis, Treatment, and Outcomes. Clinical Gastroenterology and Hepatology 13:12, pages 2062-2070.
Crossref
Crossref
Yoshitaka Hashimoto, Masahide Hamaguchi, Takao Kojima, Yasuhiro Ohshima, Akihiro Ohbora, Takahiro Kato, Naoto Nakamura & Michiaki Fukui. (2015) The modest alcohol consumption reduces the incidence of fatty liver in men: a population‐based large‐scale cohort study. Journal of Gastroenterology and Hepatology 30:3, pages 546-552.
Crossref
Crossref
Etsuko Hashimoto, Katsutoshi Tokushige & Jurgen Ludwig. (2014) Diagnosis and classification of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis: Current concepts and remaining challenges. Hepatology Research 45:1, pages 20-28.
Crossref
Crossref
Felix Stickel. 2015. Biological Basis of Alcohol-Induced Cancer. Biological Basis of Alcohol-Induced Cancer
113
130
.
K. Tsunoda, Y. Kai, K. Uchida, T. Kuchiki & T. Nagamatsu. (2014) Physical activity and risk of fatty liver in people with different levels of alcohol consumption: a prospective cohort study. BMJ Open 4:8, pages e005824-e005824.
Crossref
Crossref
Peter Dietrich & Claus Hellerbrand. (2014) Non-alcoholic fatty liver disease, obesity and the metabolic syndrome. Best Practice & Research Clinical Gastroenterology 28:4, pages 637-653.
Crossref
Crossref
J K Dyson, S McPherson & Q M Anstee. (2014) Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. Postgraduate Medical Journal 90:1063, pages 254-266.
Crossref
Crossref
Hellan K. Kwon, Joel K. Greenson & Hari S. Conjeevaram. (2013) Effect of lifetime alcohol consumption on the histological severity of non‐alcoholic fatty liver disease. Liver International 34:1, pages 129-135.
Crossref
Crossref
Melissa Palmer. 2014. Integrative Weight Management. Integrative Weight Management
145
169
.
J K Dyson, S McPherson & Q M Anstee. (2013) Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification. Journal of Clinical Pathology 66:12, pages 1033-1045.
Crossref
Crossref
Fabio Nascimbeni, Raluca Pais, Stefano Bellentani, Christopher Paul Day, Vlad Ratziu, Paola Loria & Amedeo Lonardo. (2013) From NAFLD in clinical practice to answers from guidelines. Journal of Hepatology 59:4, pages 859-871.
Crossref
Crossref
Jan Petrasek, Timea Csak, Michal Ganz & Gyongyi Szabo. (2013) Differences in innate immune signaling between alcoholic and non‐alcoholic steatohepatitis. Journal of Gastroenterology and Hepatology 28:S1, pages 93-98.
Crossref
Crossref
D. Vital Durand, J.-C. Lega, T. Fassier, T. Zenone & I. Durieu. (2013) Élévation modérée, persistante et inexpliquée des transaminases. La Revue de Médecine Interne 34:8, pages 472-478.
Crossref
Crossref
Angel Brea & José Puzo. (2013) Non-alcoholic fatty liver disease and cardiovascular risk. International Journal of Cardiology 167:4, pages 1109-1117.
Crossref
Crossref
Giulio Marchesini, Rebecca Marzocchi, Anna S. Sasdelli, Cristiana Andruccioli & Silvia Di Domizio. 2013. Non‐Alcoholic Fatty Liver Disease. Non‐Alcoholic Fatty Liver Disease
248
259
.
Achuthan Sourianarayanane, Srinivasan Dasarathy & Arthur J. McCullough. 2013. Non‐Alcoholic Fatty Liver Disease. Non‐Alcoholic Fatty Liver Disease
234
247
.
Munechika Enjoji, Kenichiro Yasutake, Motoyuki Kohjima & Makoto Nakamuta. 2013. Alcohol, Nutrition, and Health Consequences. Alcohol, Nutrition, and Health Consequences
523
532
.
Maximilian Lee & Kris V. Kowdley. (2012) Alcohol’s Effect on Other Chronic Liver Diseases. Clinics in Liver Disease 16:4, pages 827-837.
Crossref
Crossref
Varenka J. Barbero-Becerra, Jorge A. López-Velázquez, Vicente Sánchez-Valle, Misael Uribe & Nahum Méndez-Sánchez. (2012) Alcohol effects on liver diseases: good or bad buddy?. Annals of Hepatology 11:6, pages 944-948.
Crossref
Crossref
Sofia Carvalhana, Mariana Verdelho Machado & Helena Cortez-Pinto. (2012) Improving dietary patterns in patients with nonalcoholic fatty liver disease. Current Opinion in Clinical Nutrition and Metabolic Care 15:5, pages 468-473.
Crossref
Crossref
Winston Dunn, Arun J. Sanyal, Elizabeth M. Brunt, Aynur Unalp-Arida, Michael Donohue, Arthur J. McCullough & Jeffrey B. Schwimmer. (2012) Modest alcohol consumption is associated with decreased prevalence of steatohepatitis in patients with non-alcoholic fatty liver disease (NAFLD). Journal of Hepatology 57:2, pages 384-391.
Crossref
Crossref
Suthat Liangpunsakul & Naga Chalasani. (2012) What Should We Recommend to Our Patients with NAFLD Regarding Alcohol Use?. American Journal of Gastroenterology 107:7, pages 976-978.
Crossref
Crossref
Makiko Taniai, Etsuko Hashimoto, Katsutoshi Tokushige, Kazuhisa Kodama, Tomomi Kogiso, Nobuyuki Torii & Keiko Shiratori. (2011) Roles of gender, obesity, and lifestyle‐related diseases in alcoholic liver disease: Obesity does not influence the severity of alcoholic liver disease. Hepatology Research 42:4, pages 359-367.
Crossref
Crossref
Kei Nakajima. (2012) Multidisciplinary Pharmacotherapeutic Options for Nonalcoholic Fatty Liver Disease. International Journal of Hepatology 2012, pages 1-13.
Crossref
Crossref
Angel Brea Hernando & José Puzo Foncillas. (2010) Enfermedad del hígado graso no alcohólico y riesgo cardiovascular. Clínica e Investigación en Arteriosclerosis 22:6, pages 259-271.
Crossref
Crossref
T. Andrew Mixson, Charles I. Abramson & Janko Božič. (2010)
The Behavior and Social Communication of Honey Bees (
APIS Mellifera Carnica
Poll.) under the Influence of Alcohol
. Psychological Reports 106:3, pages 701-717.
Crossref
Crossref
H Janaka De Silva & Anuradha S Dassanayake. (2009) Non‐alcoholic fatty liver disease: Confronting the global epidemic requires better awareness. Journal of Gastroenterology and Hepatology 24:11, pages 1705-1707.
Crossref
Crossref